With new support from the U.S. Food and Drug Administration (FDA), Galectin Therapeutics is preparing for a late-stage clinical trial to test its therapy…
Fatty liver disease
FATTY LIVER DISEASE
ColumnsAdaptogens and MASH: To me, ‘probably fine’ is not a medical plan
It was the happy little mushroom peeking out from a trash can and winking at a neighbor across the street that grabbed my attention. No,…
FATTY LIVER DISEASE
NewsIn large trials, MASLD drug survodutide safely shrank liver fat, body weight
Survodutide, Boehringer Ingelheim’s investigational injectable therapy, significantly reduces liver fat and leads to clinically meaningful weight loss in obese or overweight people with metabolic…
FATTY LIVER DISEASE
ColumnsWhat the recent protein craze means for those of us with liver disease
YouTube is one of my guiltiest pleasures. I watch everything from cultural and historical videos to food, entertainment, and political channels, especially when the subject…
FATTY LIVER DISEASE
NewsPatient advocates sought for Fatty Liver Foundation’s hands-on fellowship
The Fatty Liver Foundation (FLF) is seeking applicants for a first-of-its-kind program that trains patient advocates to become “equal partners” in shaping research, care,…
FATTY LIVER DISEASE
NewsToday’s Global Fatty Liver Day events aim to boost awareness of SLD
Global Fatty Liver Day — being held today, on the second Thursday of June — is shining a spotlight on steatotic liver disease…
FATTY LIVER DISEASE
ColumnsHow alcohol contributes to MASH and other types of liver disease
Summers in Utah, where I grew up, meant hot days spent boating and swimming in lakes. For my friends and me, they also meant drinking…
FATTY LIVER DISEASE
ColumnsThere are ways to manage chronic pain when you’re living with MASH
I start my day every morning by swallowing a handful of pills with water I keep on my nightstand. It has been this way for…
FATTY LIVER DISEASE
NewsWegovy MASH benefits seen across patient groups in trial analyses
Treatment with Wegovy (semaglutide) showed a consistent safety and efficacy profile across a range of patient subgroups with metabolic dysfunction-associated steatohepatitis (MASH), a serious…
FATTY LIVER DISEASE
ColumnsThe importance of reading your medical records when living with MASH
Today, I sat down to go over my upcoming summer doctor appointments because ’tis the season for my annual upper and lower gastrointestinal scopes and…
Recent Posts
- Large VA study reveals hidden liver damage in US military veterans
- Uncle’s living donation saves 1-year-old girl with liver failure
- With FDA support, developer planning late-stage trial of belapectin for MASH
- A Q&A with med students helps to keep the ‘patient’ in patient care
- Heart risks in Alagille syndrome may go beyond artery narrowing